CRT 2026
Spotlight
Toby Rogers, MD, PhD
Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing)
Miho Fukui, MD, PhD
Associate Scientific Director
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States
Disclosure(s): Anteris: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Life Sciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Santiago Garcia, MD
Director, Structural Heart Program and Harold C. Schott Foundation Endowed Chair for Structural and Valvular Heart Disease
The Christ Hospital
Cincinnati, Ohio, United States
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)